| Translated title of the contribution | Additional mutations cause more aggressive tumors: MEK inhibitors offer opportunities when dealing with neuroblastoma tumors |
|---|---|
| Original language | Dutch |
| Pages (from-to) | 12-15 |
| Number of pages | 4 |
| Journal | Pharmaceutisch Weekblad |
| Volume | 154 |
| Issue number | 48 |
| Publication status | Published - 29 Nov 2019 |
| Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver